The use of powerful synthetic opioids, such as sufentanil and remifentanil, during surgery is linked to a subsequent poor ...
Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.
The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback